Algert Global’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.56M Buy
149,910
+73,241
+96% +$1.25M 0.05% 556
2025
Q1
$4.89M Buy
76,669
+1,685
+2% +$108K 0.12% 283
2024
Q4
$9.12M Buy
74,984
+5,778
+8% +$703K 0.21% 134
2024
Q3
$8.64M Buy
69,206
+6,654
+11% +$831K 0.23% 108
2024
Q2
$9.88M Buy
62,552
+795
+1% +$126K 0.33% 44
2024
Q1
$8M Buy
61,757
+15,238
+33% +$1.97M 0.31% 64
2023
Q4
$4.49M Buy
46,519
+3,337
+8% +$322K 0.18% 169
2023
Q3
$5.24M Buy
43,182
+17,670
+69% +$2.14M 0.25% 105
2023
Q2
$2.92M Buy
25,512
+4,480
+21% +$513K 0.13% 253
2023
Q1
$2.9M Sell
21,032
-31,212
-60% -$4.3M 0.14% 226
2022
Q4
$6.77M Sell
52,244
-8,426
-14% -$1.09M 0.38% 28
2022
Q3
$6.71M Buy
60,670
+17,479
+40% +$1.93M 0.41% 10
2022
Q2
$3.24M Sell
43,191
-3,812
-8% -$286K 0.24% 70
2022
Q1
$3.67M Buy
47,003
+33,066
+237% +$2.58M 0.24% 78
2021
Q4
$1.26M Hold
13,937
0.16% 206
2021
Q3
$1.29M Buy
+13,937
New +$1.29M 0.17% 148
2020
Q3
Sell
-6,138
Closed -$984K 480
2020
Q2
$984K Buy
+6,138
New +$984K 0.33% 106